Targeting GGT1 Eliminates the Tumor-Promoting Effect and Enhanced Immunosuppressive Function of Myeloid-Derived Suppressor Cells Caused by G-CSF.

Xie, Zhiqi; Kawasaki, Takahiro; Zhou, Haoyang; Okuzaki, Daisuke; Okada, Naoki; Tachibana, Masashi

Xie, Zhiqi; Kawasaki, Takahiro; Zhou, Haoyang; Okuzaki, Daisuke; Okada, Naoki; Tachibana, Masashi.

Afiliación

Xie Z; Project for Vaccine and Immune Regulation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
Kawasaki T; Project for Vaccine and Immune Regulation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
Zhou H; Project for Vaccine and Immune Regulation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
Okuzaki D; Single Cell Genomics, Human Immunology, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.
Okada N; Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Tachibana M; Project for Vaccine and Immune Regulation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.

Front Pharmacol ; 13: 873792, 2022.

Article en En | MEDLINE | ID: mdl-35548341

Palabras clave

GGT1; GGsTop; febrile neutropenia; granulocyte colony-stimulating factor; myeloid-derived suppressor cells

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google